PMID- 28630093 OWN - NLM STAT- MEDLINE DCOM- 20170928 LR - 20180127 IS - 1550-6606 (Electronic) IS - 0022-1767 (Linking) VI - 199 IP - 2 DP - 2017 Jul 15 TI - Dendritic Cell Sensing of Hydrophobic Di- and Triacylated Lipopeptides Self-Assembled within Synthetic Virus-like Particles. PG - 734-749 LID - 10.4049/jimmunol.1600521 [doi] AB - Dendritic cells (DCs) play critical roles in developing immune defenses. One important aspect is interaction with pathogen-associated molecular patterns (PAMPs)/danger-associated molecular patterns, including di- and triacylated lipopeptides. Isolated or synthetic lipopeptides are potent vaccine adjuvants, interacting with cell surface TLR2 heterodimers. In contrast, deep embedment within bacteria cell walls would impair lipopeptide interaction with cell surface TLR2, requiring degradation for PAMP recognition. Accordingly, DC processing in the absence of surface TLR2 ligation was defined using synthetic virus-like particles (SVLPs) carrying hydrophobic TLR2 PAMPs within di- and triacylated lipopeptide cores (P2Cys-SVLPs and P3Cys-SVLPs) compared with SVLPs lacking immunomodulatory lipopeptides. DCs rapidly and efficiently internalized SVLPs, which was dominated by slow endocytic processing via macropinocytosis, although some caveolar endocytosis was implicated. This delivered SVLPs primarily into macropinosomes often interacting with EEA-1(+) early endosomes. Although endoplasmic reticulum association was occasionally noted, association with recycling/sorting structures was not observed. Involvement of LysoTracker(+) structures slowly increased with time, with SVLPs present in such structures ultimately dominating. Only SVLPs carrying di- and triacylated lipopeptide cores induced DC activation and maturation independently of surface TLR2 ligation. Intracellular recognition of SVLP TLR2 ligands was confirmed by observing SVLPs' association with internal TLR2, which had similar kinetics to SVLP association with LysoTracker. This related to inflammatory cytokine induction by SVLP(+) DCs, with adaptive immune response activation ex vivo/in vivo. Importantly, particular DCs, not monocytes, recognized intracellular exposure of the TLR2 PAMPs carried by di- and triacylated SVLP cores, which indicates subset-distinct recognition of functional internal TLR2 ligands. Thus, vaccines carrying hydrophobic TLR2 ligands would interact with particular DCs for efficient induction of specific immunity in the absence of additional adjuvant. CI - Copyright (c) 2017 by The American Association of Immunologists, Inc. FAU - Sharma, Rajni AU - Sharma R AUID- ORCID: 0000-0003-0051-2308 AD - Institute of Virology and Immunology, 3147 Mittelhausern, Switzerland. FAU - Ghasparian, Arin AU - Ghasparian A AUID- ORCID: 0000-0002-0100-7461 AD - Department of Chemistry, University of Zurich, 8057 Zurich, Switzerland; and. AD - Virometix AG, 8952 Zurich, Switzerland. FAU - Robinson, John A AU - Robinson JA AD - Department of Chemistry, University of Zurich, 8057 Zurich, Switzerland; and. FAU - McCullough, Kenneth C AU - McCullough KC AUID- ORCID: 0000-0001-5325-6761 AD - Institute of Virology and Immunology, 3147 Mittelhausern, Switzerland; kmc.projects1@gmail.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20170619 PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Adjuvants, Immunologic) RN - 0 (Cytokines) RN - 0 (Lipopeptides) RN - 0 (Pathogen-Associated Molecular Pattern Molecules) RN - 0 (Toll-Like Receptor 2) RN - 0 (Vaccines, Virus-Like Particle) SB - IM MH - Adaptive Immunity MH - Adjuvants, Immunologic MH - Animals MH - Cell Differentiation MH - Cytokines/immunology MH - Dendritic Cells/*immunology/metabolism MH - Endocytosis MH - Endoplasmic Reticulum/immunology/physiology MH - Endosomes/immunology/metabolism MH - Lipopeptides/*chemistry/immunology MH - Mice MH - Monocytes/immunology/metabolism MH - Pathogen-Associated Molecular Pattern Molecules/chemistry/*immunology/metabolism MH - Sus scrofa MH - Toll-Like Receptor 2/immunology/metabolism MH - Vaccines, Virus-Like Particle/administration & dosage/chemistry/*immunology EDAT- 2017/06/21 06:00 MHDA- 2017/09/29 06:00 CRDT- 2017/06/21 06:00 PHST- 2016/04/14 00:00 [received] PHST- 2017/05/18 00:00 [accepted] PHST- 2017/06/21 06:00 [pubmed] PHST- 2017/09/29 06:00 [medline] PHST- 2017/06/21 06:00 [entrez] AID - jimmunol.1600521 [pii] AID - 10.4049/jimmunol.1600521 [doi] PST - ppublish SO - J Immunol. 2017 Jul 15;199(2):734-749. doi: 10.4049/jimmunol.1600521. Epub 2017 Jun 19.